TNON
Tenon Medical·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 3
Bearish signal 2
MACD Golden Cross
Ample Liquidity
High Gross Profit Margin
EPS Below Expectations
Revenue Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About TNON
Tenon Medical, Inc.
A medical device company that offers sacroiliac joint surgical solutions
Healthcare Equipment and Supplies
06/19/2012
04/27/2022
NASDAQ Stock Exchange
27
12-31
Common stock
104 Cooper Court, Los Gatos, CA 95032
--
Tenon Medical, Inc., was incorporated in Delaware on June 19, 2012. The Company, a medical device company founded in 2012, has developed a proprietary, FDA approved surgical implant system designed to optimize sacroiliac joint fixation/fusion surgery and corresponding outcomes. The company is preparing to roll out the system nationwide to solve the market problem of serious underservice in this field. For patients with chronic low back pain caused by the sacroiliac joint, the company's experience in clinical trials and commercial settings shows that the system introduced by Tenon may benefit patients who are correctly diagnosed and screened for surgery by trained healthcare personnel.
Earnings Call
Company Financials
EPS
TNON has released its 2025 Q3 earnings. EPS was reported at -0.4, versus the expected -0.37, missing expectations. The chart below visualizes how TNON has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
TNON has released its 2025 Q3 earnings report, with revenue of 1.17M, reflecting a YoY change of 32.24%, and net profit of -3.34M, showing a YoY change of -4.87%. The Sankey diagram below clearly presents TNON's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available



